By coculturing tumor cell lines with PDF and testing the sensitivity of targeted therapy drugs, it was found that PDF affected the efficacy of EGFR and ALK inhibitors through different degrees of activation of HGF-MET and FGF-FGFR signaling pathways. The gene discussed is ALK; the disease is neoplasm.